NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

連續血糖監測設備的全球市場:按組件(接收器,傳感器,發送器),最終用戶(家庭護理診斷,醫院)的市場研究,預測(∼2025年),COVID-19的累積影響

Continuous Glucose Monitoring Device Market Research Report by Component, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1001095
出版日期 內容資訊 英文 181 Pages
商品交期: 最快1-2個工作天內
價格
連續血糖監測設備的全球市場:按組件(接收器,傳感器,發送器),最終用戶(家庭護理診斷,醫院)的市場研究,預測(∼2025年),COVID-19的累積影響 Continuous Glucose Monitoring Device Market Research Report by Component, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 181 Pages
簡介

持續血糖監測設備的全球市場預計將從2020年的3,429,580,000美元增長到2025年底的5,484,690,000美元。

COVID-19預計將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。該調查提供了對COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場勢力動態以及政府的主要干預措施的變化。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

該報告調查了全球持續血糖監測設備市場,市場概況,市場增長和障礙分析,市場機會,COVID-19的影響,組件,最終用戶和地區,提供了系統的信息。例如不同的市場規模趨勢和預測,競爭條件以及主要公司的概況。

目錄

第1章簡介

  • 調查目的
  • 市場細分和覆蓋範圍
  • 考慮調查的年份
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 已發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 市場展望
  • 組件展望
  • 最終用戶展望
  • 區域展望
  • 競爭對手展望

第4章市場概述

  • COVID-19的累積效果

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • 挑戰
  • 波特五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章按組成部分

  • 接收器
  • 傳感器
  • 發射器

第7章最終用戶

  • 家庭護理診斷
  • 醫院

第8章美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章歐洲,中東/非洲

  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第11章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 競爭情景
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎賞,表彰,擴大

第12章企業可用性簡介

  • Abbott Laboratories
  • Baxter International Inc
  • Bayer AG
  • Dexcom Inc.
  • Echo Therapeutics, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • GlySens Incorporated
  • Insulet Corporation
  • Johnson & Johnson Services Inc
  • Medtronic PLC
  • Medtrum Technologies, Inc
  • Menarini Diagnostics
  • Microchip Technology Inc
  • Micron Technology Inc.
  • Nemaura Medical, Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Senseonics Holdings
  • Tandem Diabetes Care
  • Texas Instruments Inc
  • Ypsomed AG

第13章附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-7C5681F86866

The Global Continuous Glucose Monitoring Device Market size was estimated at USD 3,429.57 Million in 2020 and expected to reach USD 3,784.38 Million in 2021, at a Compound Annual Growth Rate (CAGR) 10.68% to reach USD 6,305.90 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Continuous Glucose Monitoring Device to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Component, the Continuous Glucose Monitoring Device Market was studied across Receivers, Sensors, and Transmitters.

Based on End-User , the Continuous Glucose Monitoring Device Market was studied across Homecare diagnostics and Hospitals.

Based on Geography, the Continuous Glucose Monitoring Device Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Continuous Glucose Monitoring Device Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Continuous Glucose Monitoring Device Market, including Abbott Laboratories, Baxter International Inc, Bayer AG, Dexcom Inc., Echo Therapeutics, Inc., F. Hoffmann-La Roche AG, GE Healthcare, GlySens Incorporated, Insulet Corporation, Johnson & Johnson Services Inc, Medtronic PLC, Medtrum Technologies, Inc, Menarini Diagnostics, Microchip Technology Inc, Micron Technology Inc., Nemaura Medical, Inc., Novo Nordisk A/S, Pfizer Inc., Senseonics Holdings, Tandem Diabetes Care, Texas Instruments Inc, and Ypsomed AG.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Continuous Glucose Monitoring Device Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Continuous Glucose Monitoring Device Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Continuous Glucose Monitoring Device Market?
  • 4. What is the competitive strategic window for opportunities in the Global Continuous Glucose Monitoring Device Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Continuous Glucose Monitoring Device Market?
  • 6. What is the market share of the leading vendors in the Global Continuous Glucose Monitoring Device Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Continuous Glucose Monitoring Device Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Component Outlook
  • 3.4. End-User Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of diabetes and cardiovascular diseases require regular and continuous monitoring for a lifetime
      • 5.1.1.2. Growing demand for home-based treatment and self-medication to manage irregular chronic and acute illnesses
      • 5.1.1.3. Rising demand for less invasive products
    • 5.1.2. Restraints
      • 5.1.2.1. Surge in the price of CGM devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and excessive research & development
      • 5.1.3.2. Developing awareness regarding the use of CGM devices in emerging countries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of accuracy of CGM devices
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Continuous Glucose Monitoring Device Market, by Component

  • 6.1. Introduction
  • 6.2. Receivers
  • 6.3. Sensors
  • 6.4. Transmitters

7. Continuous Glucose Monitoring Device Market, by End-User

  • 7.1. Introduction
  • 7.2. Homecare diagnostics
  • 7.3. Hospitals

8. Americas Continuous Glucose Monitoring Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Continuous Glucose Monitoring Device Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Continuous Glucose Monitoring Device Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Baxter International Inc
  • 12.3. Bayer AG
  • 12.4. Dexcom Inc.
  • 12.5. Echo Therapeutics, Inc.
  • 12.6. F. Hoffmann-La Roche AG
  • 12.7. GE Healthcare
  • 12.8. GlySens Incorporated
  • 12.9. Insulet Corporation
  • 12.10. Johnson & Johnson Services Inc
  • 12.11. Medtronic PLC
  • 12.12. Medtrum Technologies, Inc
  • 12.13. Menarini Diagnostics
  • 12.14. Microchip Technology Inc
  • 12.15. Micron Technology Inc.
  • 12.16. Nemaura Medical, Inc.
  • 12.17. Novo Nordisk A/S
  • 12.18. Pfizer Inc.
  • 12.19. Senseonics Holdings
  • 12.20. Tandem Diabetes Care
  • 12.21. Texas Instruments Inc
  • 12.22. Ypsomed AG

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2020 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2026
  • FIGURE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY RECEIVERS, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY RECEIVERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY SENSORS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY SENSORS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY TRANSMITTERS, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY TRANSMITTERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2020 VS 2026 (%)
  • FIGURE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2020 VS 2026 (USD MILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2026
  • FIGURE 19. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE DIAGNOSTICS, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 24. AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 26. ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 27. BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 28. CANADA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 29. MEXICO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 30. UNITED STATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 31. CALIFORNIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. FLORIDA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. ILLINOIS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. NEW YORK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. OHIO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. PENNSYLVANIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. TEXAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 39. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 41. CHINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. INDIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. INDONESIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. JAPAN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. MALAYSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. PHILIPPINES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. THAILAND CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 50. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 52. FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. NETHERLANDS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. QATAR CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 64. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 65. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY RECEIVERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY SENSORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY TRANSMITTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. ARGENTINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. BRAZIL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. CANADA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. CANADA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. MEXICO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. MEXICO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. UNITED STATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. UNITED STATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CALIFORNIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. CALIFORNIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. FLORIDA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. FLORIDA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ILLINOIS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. ILLINOIS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. NEW YORK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. NEW YORK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. OHIO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. OHIO CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. PENNSYLVANIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. PENNSYLVANIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. TEXAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. TEXAS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CHINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. CHINA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. INDIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. INDIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. INDONESIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDONESIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. JAPAN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. JAPAN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. MALAYSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. MALAYSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. PHILIPPINES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PHILIPPINES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. THAILAND CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. THAILAND CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. NETHERLANDS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. NETHERLANDS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. QATAR CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. QATAR CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SIZE, BY END-USER , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: SCORES
  • TABLE 83. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: BUSINESS STRATEGY
  • TABLE 84. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: PRODUCT SATISFACTION
  • TABLE 85. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: RANKING
  • TABLE 86. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 87. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: SHARE, BY COMPANY, 2020
  • TABLE 88. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: MERGER & ACQUISITION
  • TABLE 89. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 90. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 91. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: INVESTMENT & FUNDING
  • TABLE 92. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 93. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: LICENSE & PRICING
  • TABLE 94. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICE MARKET: CONTACT DETAILS